DEPLOYDatabase

Deployment

Toumai at Rome

The Toumai Endoscopic Surgical Robot is MicroPort MedBot's flagship laparoscopic surgical robotics system, featuring remote telesurgery capabilities. It became the world's first surgical robot to receive regulatory approval for commercial remote surgery in April 2025, and has been deployed in nearly 40 countries across six continents.

Toumai has achieved 100+ commercial orders and 80+ installations worldwide, with notable deployments including Cleveland Clinic Abu Dhabi, Gemelli Hospital Italy, and AZ Delta Belgium.

Toumai by MicroPort MedBot · Catalog entry · 1 source · not yet field-verified · Surgical robots

Track Toumai at Rome

Recent coverage

See all coverage →

Gemelli Hospital in Italy completed over 50 cases using Toumai

Key facts

Cases
50+ procedures completed

Exposure

Customer segment
healthcare
Scale tier
commercial 10 99

Each exposure value carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.

Safety record

No incidents on record for Toumai at Rome.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Trust tier
Catalog entry · 1 source · not yet field-verifiedhow tiers work →
Last updated
2026-08-21
Model
Toumai
Company
MicroPort MedBot
Location
Italy/Rome
Operator
MicroPort MedBot
Status
operational
Scale at site
11 to 100 units
Site environment
indoor
Location precision
verified coordinates
First seen
2024-01-01
ID
b27a2bd0-1011-4f62-8b3e-1a380510f38a

Timeline

  1. Jan 2024
    First recorded
    Toumai first documented operating at Rome.
  2. Aug 2026
    Current status: operational, reviewed
    Latest recorded state. New status transitions append here as the deployment-status recorder produces them.

On the deployment map

Free to use on your site, with a link back to DEPLOY.

Toumai operates in Rome. Explore the full verified map:

Sources (1)

  1. Toumai Achieves Global Commercialization Milestone · https://microport.com/news/toumai-surgical-robot-achieves-global-commercialization-milestone-with-100-orders · 2025-10-09
Methodology: Verified · 1 source (1 primary) · last reviewed 2026-08-21

Verification posture

Verified

High confidence

Review state

Stable

Last reviewed 2026-08-21

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: surgical

Sources by quality tier

1
primary-company-ir
Company IR disclosure

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Toumai at Rome.

Common questions

What is the Toumai deployment at Rome?
Toumai, built by MicroPort MedBot, is recorded as a deployment at Rome on the DEPLOY registry. MicroPort MedBot operates the deployment directly.
Who operates Toumai at Rome?
MicroPort MedBot, the manufacturer of Toumai, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
When did the Toumai deployment at Rome go live?
The deployment is recorded as starting January 1, 2024 on the DEPLOY registry. Earlier activity may exist but is not yet sourced.
Have there been incidents at the Toumai deployment at Rome?
No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.

Deploy Watch

Track this deployment.

We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.

Machine-readable surfaces